Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Medicine,General Medicine
Reference36 articles.
1. Z. Chen, H. Xie, M. Hu, T. Huang, Y. Hu, N. Sang, Y. Zhao, Recent progress in treatment of hepatocellular carcinoma. Am. J. Cancer Res. 10, 2993–3036 (2020)
2. T. Otto, P. Sicinski, Cell cycle proteins as promising targets in cancer therapy. Nat. Rev. Cancer 17, 93–115 (2017)
3. A. Jindal, A. Thadi, K. Shailubhai, Hepatocellular Carcinoma: Etiology and Current and Future Drugs. J. Clin. Exp. Hepatol. 9, 221–232 (2019)
4. X. Qing, W. Xu, J. Zong, X. Du, H. Peng, Y. Zhang, Emerging treatment modalities for systemic therapy in hepatocellular carcinoma. Biomark. Res 9, 64 (2021)
5. M. Malumbres, M. Barbacid, Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 9, 153–166 (2009)